News

Latest News

May 16, 2022 Press Release
Washington, D.C. (May 16, 2022) – TOMORROW, May 17, 2022, at 11:45 a.m. ET, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, will hold a hybrid hearing entitled “Underpaid, Overworked, and Underappreciated: How the Pandemic Economy Disproportionately Harmed Low-Wage Women Workers” to examine how gender inequities in the workforce have been exacerbated by the pandemic, particularly for low-wage, hourly workers, who are disproportionately women and women of color.
May 12, 2022 Press Release
Washington, D.C. (May 12, 2022) – Today, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, released a new staff report detailing how meatpacking companies engaged Trump Administration political appointees in an aggressive campaign to force workers to remain in dangerous plants with high risk of coronavirus transmission.  The report reveals how industry representatives successfully enlisted USDA’s assistance in weakening federal worker protections and insulating facilities from state and local health department regulations.
May 10, 2022 Press Release
Washington, D.C. (May 10, 2022)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, released a staff report on their joint investigation into coronavirus vaccine manufacturing failures of Emergent BioSolutions, Inc. (Emergent) under a contract awarded by the Trump Administration despite the company’s history of serious deficiencies. 
May 9, 2022 Press Release
Washington, D.C. (May 9, 2022) – Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, issued the following statement after a staff briefing by Dr. Peter Marks, Director for the Center of Biologics Evaluation and Research at the Food and Drug Administration (FDA), on the status of coronavirus vaccine candidates for young children that took place on the afternoon of May 6.
May 3, 2022 Press Release
Washington, D.C. (May 3, 2022) – Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, issued the following statement praising President Biden’s nomination of Carlos Felipe Uriarte to be Assistant Attorney General for Legislative Affairs at the U.S. Department of Justice:
Apr 29, 2022 Press Release
Washington, D.C. (April 29, 2022) – Today, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, held a hearing with Government Accountability Office (GAO) officials and scientific experts to discuss a new GAO report on scientific integrity at public health agencies, and the Select Subcommittee’s findings of extensive political interference by the Trump Administration in the nation’s coronavirus response.  The hearing detailed the harm caused when political officials interfere with scientific work and how implementing the recommendations proposed in GAO’s report and other steps taken by the Biden Administration are helping to prevent the type of political interference the Select Subcommittee continues to unearth and document. 
Apr 29, 2022 Press Release
Washington, D.C. (April 29, 2022) – Below is Select Subcommittee on the Coronavirus Crisis Chairman James E. Clyburn’s opening statement, as delivered, for today’s hearing with Government Accountability Office officials and experts on “Ensuring Scientific Integrity at Our Nation’s Public Health Agencies.”
Apr 29, 2022 Press Release
Washington, D.C. (April 29, 2022) – Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, released new evidence from the Select Subcommittee’s ongoing investigation into the Trump Administration’s political interference in the nation’s coronavirus response in advance of a hearing at 9:00 a.m. ET on ensuring scientific integrity in the nation’s public health agencies.  Consistent with a recent report from the Government Accountability Office (GAO)—which found that government scientists observed incidents of political interference in scientific decision-making but did not report them for fear of retaliation or because they believed superiors already knew—today’s evidence sheds new light on the extent to which Trump Administration officials overruled, undermined, and muzzled career public health experts during the critical first year of the pandemic.   
Apr 27, 2022 Press Release
Washington, D.C. (April 27, 2022) – Today, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, released a staff report that lays out troubling new evidence regarding the Trump Administration’s approval of a $700 million loan under the Coronavirus Aid, Relief and Economic Security (CARES) Act program for companies “critical to maintaining national security.”  This loan to trucking company YRC Worldwide Inc. (now named Yellow Corporation) represented 95% of the total funds disbursed under the CARES Act national security loan program. 
Apr 25, 2022 Press Release
Washington, D.C. (April 25, 2022) – Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, sent a letter to Food and Drug Administration (FDA) Commissioner Dr. Robert M. Califf requesting a staff briefing on the status of coronavirus vaccine candidates for young children.

Pages